What development phase is Vasodistal in?

Vasodistal is FDA-approved (marketed).

What is the generic name of Vasodistal?

CINEPAZIDE is the generic (nonproprietary) name of Vasodistal.

Last reviewed 2026-04-20 · How we verify

Vasodistal (CINEPAZIDE)

FDA-approved withdrawn Small molecule Quality 6/100

At a glance

Generic name	CINEPAZIDE
Drug class	cinepazide
Modality	Small molecule
Therapeutic area	Hematology
Phase	FDA-approved
First approval	1980

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke (NA)
Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction (PHASE2)
Mildronate for Acute Ischemic Stroke (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Vasodistal CI brief — competitive landscape report
Vasodistal updates RSS · CI watch RSS